0001719960-20-000002.txt : 20200226 0001719960-20-000002.hdr.sgml : 20200226 20200226162139 ACCESSION NUMBER: 0001719960-20-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(7) FILED AS OF DATE: 20200226 DATE AS OF CHANGE: 20200226 EFFECTIVENESS DATE: 20200226 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MPM ONCOLOGY INNOVATIONS FUND LP CENTRAL INDEX KEY: 0001719960 IRS NUMBER: 821760795 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-315855 FILM NUMBER: 20656023 BUSINESS ADDRESS: STREET 1: 450 KENDALL STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-425-9200 MAIL ADDRESS: STREET 1: 450 KENDALL STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: MPM ONCOLOGY INNOVATIONS FUND L.P. DATE OF NAME CHANGE: 20171017 D/A 1 primary_doc.xml X0708 D/A LIVE 0001719960 MPM ONCOLOGY INNOVATIONS FUND LP 450 KENDALL STREET CAMBRIDGE MA MASSACHUSETTS 02142 617-425-9200 DELAWARE MPM ONCOLOGY INNOVATIONS FUND L.P. Limited Partnership true 2017 N/A MPM Oncology Innovations Fund GP LLC 450 Kendall Street Cambridge MA MASSACHUSETTS 02142 Executive Officer Promoter The General Partner of the Issuer. Ansbert Gadicke c/o MPM Oncology Innovations Fund LP 450 Kendall Street Cambridge MA MASSACHUSETTS 02142 Executive Officer Promoter Dr. Gadicke is the Manager of the General Partner of the Issuer. Luke Evnin c/o MPM Oncology Innovations Fund LP 450 Kendall Street Cambridge MA MASSACHUSETTS 02142 Executive Officer Promoter Dr. Evnin is the Manager of the General Partner of the Issuer. Pooled Investment Fund Venture Capital Fund false Decline to Disclose 06b 3C 3C.7 true 0001567619-19-014141 2018-07-12 true true true Limited Partnership Interests. The General Partner may waive the minimum capital commitment of $250,000 in its sole discretion. false 0 None None UBS Financial Services Inc. 8174 1285 Avenue of the Americas New York NY NEW YORK 10019 All States false 98879004 98879004 0 false 36 0 true 0 INVESTORS WHO ARE CLIENTS OF UBS FINANCIAL SERVICES INC. ("UBS") MAY PAY TO UBS A FEE OF UP TO 2% OF THEIR COMMITMENT. ALSO, THE MANAGEMENT COMPANY PAYS TO UBS A PORTION OF THE MANAGEMENT FEE OTHERWISE PAID TO IT BY THE FUND IN RESPECT OF SUCH INVESTORS. 0 true Certain persons named in Item 3 or affiliate(s) thereof may receive payments deemed to be made from the proceeds of the offering, including management fees. The amount of such payments cannot be estimated at this time. false MPM ONCOLOGY INNOVATIONS FUND LP ANSBERT GADICKE ANSBERT GADICKE MANAGER OF THE GENERAL PARTNER OF THE ISSUER 2020-02-26